So IMU cancelled it's engagement with ALA because it has an...

So IMU cancelled it's engagement with ALA because it has an "embarrassment of riches" which requires "prioritisation".

An excellent presentation without giving much away. It's why the recently published results of Yuman Fong and his team's independent trial involving the deadliest of cancers ... pancreatic cancer ... provides such a valuable glimpse into what is happening behind the scenes. BP will surely have taken note of those amazing results.

Dr Glover says towards the end: "The technology is fantastic. The ability to go after hematalogic cancers as well as solid tumours, and not just in a been there done that type of a way, but if you look at oncarlytics and what it can deliver, it's fantastic and we really have an opportunity to make some inroads here into cancer."